article thumbnail

Marijuana Products May Ease Autism Symptoms Says Study

The Joint Blog

According to a new study published in the journal Seminars in Pediatric Neurology, marijuana-based products are associated with improvements in the symptoms of autistic patients who have self-injurious behaviors and co-morbid epilepsy. Those diagnosed with both ASD and epilepsy saw a 91% seizure control improvement.

article thumbnail

Navigating Ohio’s Medical Marijuana Dispensaries: A Comprehensive Guide for Patients

MMJ Recs

A: Qualifying medical conditions in Ohio include cancer, PTSD, chronic pain, epilepsy, and more. Dispensary Educational Seminars: Many dispensaries in Ohio offer educational seminars and workshops covering topics such as cannabis science, product selection, and consumption methods.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. upcoming seminars). Conclusions. Palliative care indications. Cancer pain. Neuropathic pain. 2019 ; Sarris et al.

article thumbnail

Five Things to Know About Hemp-CBD in Pet Products

Canna Law Blog

That changed when I started looking into Hemp CBD pet products in preparing for a CLE put on by the Seminar Group. THC binds to the CB1 receptors, but the way that CBD interacts with ECS is not fully understood in humans or animals, despite the fact that Epidiolex has been approved as a drug for treating epilepsy.

Pets 78
article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

In 2020, CBD is available three ways: over the counter; at state-licensed marijuana dispensaries; or if you have certain forms of epilepsy, from GW Pharmaceuticals. For years, he’d been determined to connect the nascent CBD research he heard about at symposiums abroad with the medical marijuana movement in California.

CBD 40